Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Shoulder Innovations to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
OrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Guardant Health to Participate in Upcoming Investor Conferences
-
Discovery 2026 Short Duration LP Closing August 12, 2026 – Maximum $35,000,000
-
Claranova: FY 2025-2026 Revenue
-
Updated Mineral Resource Estimate and publication of Competent Persons Report
-
Candel Therapeutics to Present at Canaccord Genuity’s 46th Annual Growth Conference in Boston
-
Advantage Solutions to Participate in The Canaccord Annual Growth Conference on August 12, 2026
-
Scholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference
-
BioHarvest Sciences to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Publication of Prospectus
-
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
QuantumCore to Present at Canaccord Genuity's 46th Annual Growth Conference
-
BlackBerry to Participate in Canaccord Genuity's 46th Annual Growth Conference
-
Form 8.3 - [ANIMALCARE GROUP PLC - 28 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 28 07 2026] - (CGWL)
-
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Cipher Digital Announces Participation in Upcoming Investor and Industry Conferences
-
1stDibs to Participate in Upcoming Investor Conference
-
REPAY to Attend Upcoming Investor Conferences
-
Artivion to Participate in Upcoming Investor Conferences
-
Ceribell to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Pulmonx to Present at the Canaccord Genuity 46th Annual Growth Conference
-
Veracyte to Participate in Upcoming Investor Conferences
-
Tandem Diabetes Care Announces Upcoming Conference Presentation
-
PacBio to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Delcath Systems to Participate at the Canaccord Genuity 46th Annual Growth Conference
-
Next Bridge Hydrocarbons Releases Share Registration Data
-
Net Asset Value(s)
-
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
-
ATAI Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of AtaiBeckley to Eli Lilly
-
Exagen Inc. to Participate in Upcoming Investor Conference
-
Pasqal to Participate in Upcoming Investor Conferences
-
AngioDynamics to Participate in Upcoming Investor Conferences
-
CVRx to Present at Canaccord Genuity's 46th Annual Growth Conference
-
QuickLogic to Report Second Quarter 2026 Financial Results on Tuesday, August 11 and Participate in Key Investor Conferences in the Third Quarter
-
SharkNinja to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
-
Form 8.3 - [ANIMALCARE GROUP PLC - 27 07 2026] - (CGWL)
-
Form 8.3 - [ADVANCED MEDICAL SOLUTIONS GROUP PLC - 27 07 2026] - (CGWL)
-
Niagen Bioscience to Present at Canaccord Genuity’s 46th Annual Growth Conference
-
Entera Bio prices $275M private placement led by BVF Partners
-
Entera Bio prices $275 million private placement led by BVF Partners
-
CoinShares CEO Jean-Marie Mognetti to Participate in Fireside Chat at Canaccord Genuity 46th Annual Growth Conference in Boston
-
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
-
Entera Bio Announces Pricing of Oversubscribed $275 Million Private Placement
-
AtriCure to Participate at Upcoming Investor Conferences
-
PPHC to Report Second Quarter 2026 Financial Results and Present at Upcoming Investor Conference


